Alpha Tau Medical Ltd
Research Alpha Tau Medical Ltd (DRTS) on Bullrun: market cap USD 1.36B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDRTS
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.36B
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 22.94M
Valuation Snapshot
latest market cap is USD 1.36B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 42.63M | -USD 32.76M | n/a | -0.53 | USD 12.20M | USD 13.73M | USD 77.10M |
| FY2024 | USD 0 | -USD 31.75M | -USD 22.02M | n/a | -0.45 | USD 13.72M | USD 12.54M | USD 62.67M |
| FY2023 | USD 0 | -USD 29.16M | -USD 24.36M | n/a | -0.42 | USD 12.66M | USD 13.28M | USD 84.48M |
| FY2022 | USD 0 | -USD 33.76M | -USD 24.78M | n/a | -0.53 | USD 5.84M | n/a | USD 105.66M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.36B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 435.65M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 218.18M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 209.12M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 219.46M | n/a | n/a | n/a |
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Alpha Tau Medical Ltd's market cap?
Alpha Tau Medical Ltd's market capitalization is USD 1.36B.
What does Alpha Tau Medical Ltd do?
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer.